Active Biotech focuses the operations on the laquinimod project and adjusts the organization

LUND, Sweden, June 1, 2015 — Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that the company has made a notification of planned redundancies of 47 of its employees, which means a…

Source: www.fiercebiotech.com

---